Detection of wild poliovirus type 3 in the Netherlands

In a recent study published in the journal Eurosurveillance, researchers detected wild poliovirus type 3 (WPV3) during the environmental surveillance of poliovirus essential facilities (PEFs) in the Netherlands.

Study: Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023. Image Credit: Juan Gaertner / Shutterstock.com

Study: Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023. Image Credit: Juan Gaertner / Shutterstock.com

About the study

Environmental surveillance of all PEFs in the Netherlands was implemented to identify possible containment breaches. As a result, the WPV3 Saukett G strain was isolated from a sewage sample on November 15, 2022, by the National Polio Laboratory. Soon after, a prompt response to trace possible WPV3 shedding was essential to mitigate the risk.

In the present study, researchers describe the identification, isolation, and surveillance of WPV3 shedding. The national authority for containment of poliovirus (NAC) ordered routine environmental surveillance of PEFs since 2020. Wastewater samples from polio diagnostic labs, toilets, and vaccine production facilities were collected.

Study findings

Sewage samples were obtained every three weeks in 2022. Seventy-four PEF samples were analyzed, all of which tested negative for infectious polovirus, except for one sample.

The positive sample yielded two isolates. Genome sequencing subsequently revealed that the isolates were WPV3-Saukett G strains with two and three mutations relative to the vaccine stocks.

Follow-up samples from the same site were negative. Mutations in the two isolates suggested human shedding, rather than a breach from the PEF.

Serum and stool samples were collected from 51 employees with access to WPV3. Stool specimens were assessed using in-house reverse-transcription polymerase chain reaction (RT-PCR) assays for enterovirus or WPV3 detection.

PEF employees were vaccinated, while one exhibited a serologic response to infection. Stool specimens from this individual tested positive for enterovirus and WPV3, with the remaining stool samples testing negative. The infected employee was asked to isolate at a PEF residence under the supervision of public health service.

The infected employee was allowed walk, exercise, and meet outsiders while avoiding physical contact but was prohibited from receiving guests within the isolation residence. The infected individual was provided psychological support during isolation. Isolation ended after 33 days when three successive stool specimens tested negative.

A throat swab was obtained during isolation when the virus load in the stool sample increased on December 13, 2022. This sample tested negative for WPV3/enterovirus, thus implying that oral transmission was unlikely and stringent hygiene measures could prevent secondary transmission.

The genomes of isolates from sewage and stool specimens were not identical, although one substitution (C3082T) was shared. This suggested that the infected employee was the likely source of the sewage isolate.

PEF and local health service began contact tracing after identifying the infected employee. Specifically, close contacts and others sharing the same toilet space were identified. In total, 54 stool samples from 27 contacts tested negative for WPV3.

Conclusions

In summary, the researchers described an asymptomatic infection of WPV3 in a vaccinated employee after detecting the virus through environmental surveillance of Dutch PEFs. WPV detection in sewage indicated a containment breach, which triggered a response to identify the virus-shedding employee.

There were no indications of ongoing transmission and swab samples from the infected individual were negative. Thus, stringent hygiene measures were sufficient for risk mitigation.

The study findings demonstrate that environmental surveillance could prove valuable when containment breaches and infection remain unnoticed.

Journal reference:
  • Duizer, E., Ruijs, W. L., Hintaran, A. D. P.,, et al. (2023). Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023. Eurosurveillance. doi:10.2807/1560-7917.ES.2023.28.5.2300049
Tarun Sai Lomte

Written by

Tarun Sai Lomte

Tarun is a writer based in Hyderabad, India. He has a Master’s degree in Biotechnology from the University of Hyderabad and is enthusiastic about scientific research. He enjoys reading research papers and literature reviews and is passionate about writing.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sai Lomte, Tarun. (2023, February 08). Detection of wild poliovirus type 3 in the Netherlands. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20230208/Detection-of-wild-poliovirus-type-3-in-the-Netherlands.aspx.

  • MLA

    Sai Lomte, Tarun. "Detection of wild poliovirus type 3 in the Netherlands". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20230208/Detection-of-wild-poliovirus-type-3-in-the-Netherlands.aspx>.

  • Chicago

    Sai Lomte, Tarun. "Detection of wild poliovirus type 3 in the Netherlands". News-Medical. https://www.news-medical.net/news/20230208/Detection-of-wild-poliovirus-type-3-in-the-Netherlands.aspx. (accessed November 24, 2024).

  • Harvard

    Sai Lomte, Tarun. 2023. Detection of wild poliovirus type 3 in the Netherlands. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20230208/Detection-of-wild-poliovirus-type-3-in-the-Netherlands.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cleveland Clinic presents new findings on triple-negative breast cancer vaccine